| Triggering and resolution of inflammation in NASH S Schuster, D Cabrera, M Arrese, AE Feldstein Nature reviews Gastroenterology & hepatology 15 (6), 349-364, 2018 | 836 | 2018 |
| Innate immunity and inflammation in NAFLD/NASH M Arrese, D Cabrera, AM Kalergis, AE Feldstein Digestive diseases and sciences 61, 1294-1303, 2016 | 524 | 2016 |
| Role of oxidative stress as key regulator of muscle wasting during cachexia J Ábrigo, AA Elorza, CA Riedel, C Vilos, F Simon, D Cabrera, L Estrada, ... Oxidative medicine and cellular longevity 2018 (1), 2063179, 2018 | 204 | 2018 |
| Renin‐angiotensin system: an old player with novel functions in skeletal muscle C Cabello‐Verrugio, MG Morales, JC Rivera, D Cabrera, F Simon Medicinal research reviews 35 (3), 437-463, 2015 | 179 | 2015 |
| Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-β signalling MJ Acuña, P Pessina, H Olguin, D Cabrera, CP Vio, M Bader, ... Human molecular genetics 23 (5), 1237-1249, 2014 | 176 | 2014 |
| Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy MG Morales, J Gutierrez, C Cabello-Verrugio, D Cabrera, KE Lipson, ... Human molecular genetics 22 (24), 4938-4951, 2013 | 166 | 2013 |
| Decorin interacts with connective tissue growth factor (CTGF)/CCN2 by LRR12 inhibiting its biological activity C Vial, J Gutiérrez, C Santander, D Cabrera, E Brandan Journal of Biological Chemistry 286 (27), 24242-24252, 2011 | 128 | 2011 |
| Liver dysfunction as a novel player in Alzheimer’s progression: looking outside the brain LD Estrada, P Ahumada, D Cabrera, JP Arab Frontiers in aging neuroscience 11, 174, 2019 | 127 | 2019 |
| CTGF/CCN‐2 over‐expression can directly induce features of skeletal muscle dystrophy MG Morales, C Cabello‐Verrugio, C Santander, D Cabrera, ... The Journal of pathology 225 (4), 490-501, 2011 | 126 | 2011 |
| Increase in decorin and biglycan in Duchenne Muscular Dystrophy: role of fibroblasts as cell source of these proteoglycans in the disease R Fadic, V Mezzano, K Alvarez, D Cabrera, J Holmgren, E Brandan Journal of cellular and molecular medicine 10 (3), 758-769, 2006 | 121 | 2006 |
| High fat diet‐induced skeletal muscle wasting is decreased by mesenchymal stem cells administration: implications on oxidative stress, ubiquitin proteasome pathway activation … J Abrigo, JC Rivera, J Aravena, D Cabrera, F Simon, F Ezquer, M Ezquer, ... Oxidative medicine and cellular longevity 2016 (1), 9047821, 2016 | 118 | 2016 |
| Angiotensin II receptor type 1 blockade decreases CTGF/CCN2‐mediated damage and fibrosis in normal and dystrophic skeletal muscles C Cabello‐Verrugio, MG Morales, D Cabrera, CP Vio, E Brandan Journal of cellular and molecular medicine 16 (4), 752-764, 2012 | 111 | 2012 |
| Novel and optimized strategies for inducing fibrosis in vivo: focus on Duchenne Muscular Dystrophy P Pessina, D Cabrera, MG Morales, CA Riquelme, J Gutiérrez, ... Skeletal muscle 4, 1-17, 2014 | 105 | 2014 |
| UDCA, NorUDCA, and TUDCA in liver diseases: a review of their mechanisms of action and clinical applications D Cabrera, JP Arab, M Arrese Bile Acids and Their Receptors, 237-264, 2019 | 97 | 2019 |
| Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth … MG Morales, D Cabrera, C Céspedes, CP Vio, Y Vazquez, E Brandan, ... Cell and tissue research 353 (1), 173-187, 2013 | 93 | 2013 |
| Mitochondrial dysfunction in skeletal muscle pathologies J Abrigo, F Simon, D Cabrera, C Vilos, C Cabello-Verrugio Current Protein and Peptide Science 20 (6), 536-546, 2019 | 90 | 2019 |
| Andrographolide ameliorates inflammation and fibrogenesis and attenuates inflammasome activation in experimental non-alcoholic steatohepatitis D Cabrera, A Wree, D Povero, N Solís, A Hernandez, M Pizarro, ... Scientific reports 7 (1), 3491, 2017 | 90 | 2017 |
| Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas MG Morales, J Abrigo, MJ Acuña, RA Santos, M Bader, E Brandan, ... Disease models & mechanisms 9 (4), 441-449, 2016 | 84 | 2016 |
| High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data LA Díaz, F Idalsoaga, M Cannistra, R Candia, D Cabrera, F Barrera, ... World journal of gastroenterology 26 (48), 7693, 2020 | 79 | 2020 |
| Beneficial effects of mineralocorticoid receptor blockade in experimental non‐alcoholic steatohepatitis M Pizarro, N Solís, P Quintero, F Barrera, D Cabrera, ... Liver International 35 (9), 2129-2138, 2015 | 72 | 2015 |